Norikazu Yabuta Selected Research

Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)

8/2011	The tumor suppressor Lats2 is pivotal in Aurora A and Aurora B signaling during mitosis.
11/2008	Lats2 is a negative regulator of myocyte size in the heart.
5/2004	The centrosomal protein Lats2 is a phosphorylation target of Aurora-A kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norikazu Yabuta Research Topics

Disease

12	Neoplasms (Cancer) 02/2019 - 03/2006
4	Carcinogenesis 11/2015 - 03/2006
2	Mouth Neoplasms (Oral Cancer) 01/2022 - 02/2019
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2019 - 12/2017
2	Vasculitis (Vasculitides) 01/2019 - 08/2008
2	Carcinoma (Carcinomatosis) 09/2018 - 12/2012
2	Osteosarcoma (Osteogenic Sarcoma) 10/2017 - 01/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 01/2014
2	Hypertrophy 02/2013 - 11/2008
2	Warts (Wart) 11/2008 - 05/2004
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2007 - 03/2006
1	Infertility (Sterility) 04/2024
1	Squamous Cell Carcinoma of Head and Neck 02/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2015
1	Adenocarcinoma 01/2015
1	Necrosis 01/2015
1	Chromosomal Instability (Chromosome Stability) 01/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 08/2008
1	Neoplasm Metastasis (Metastasis) 07/2007
1	Melanoma (Melanoma, Malignant) 07/2007
1	Polyploidy 10/2006
1	Epilepsy (Aura) 08/2006
1	Vascular Remodeling 02/2006

Drug/Important Bio-Agent (IBA)

9	Phosphotransferases (Kinase)IBA 01/2022 - 05/2004
3	Messenger RNA (mRNA)IBA 01/2019 - 08/2006
3	Proteins (Proteins, Gene)FDA Link 09/2018 - 11/2010
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2011 - 05/2004
2	Long-Acting Thyroid Stimulator (LATS)IBA 01/2022 - 05/2004
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019 - 12/2017
2	Complementary DNA (cDNA)IBA 09/2018 - 08/2008
2	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 08/2008
2	Gefitinib (Iressa)FDA Link 01/2014 - 01/2011
2	MicroRNAs (MicroRNA)IBA 01/2007 - 03/2006
1	Male Contraceptive Agents (Male Contraceptives)IBA 04/2024
1	Contraceptive Agents (Contraceptives)IBA 04/2024
1	LectinsIBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	AcyltransferasesIBA 09/2018
1	Hedgehog ProteinsIBA 09/2018
1	FicolinsIBA 12/2017
1	Immunoglobulins (Immunoglobulin)IBA 12/2017
1	Peptides (Polypeptides)IBA 10/2017
1	Amino Acids FDA Link 10/2017
1	Indicators and Reagents (Reagents)IBA 11/2015
1	Cyclin G2IBA 11/2015
1	withaferin AIBA 01/2015
1	AndrogensIBA 01/2015
1	Cyclin GIBA 01/2014
1	ClathrinIBA 01/2014
1	LuteolinIBA 01/2014
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 02/2013
1	Tamoxifen FDA LinkGeneric 12/2012
1	ErbB Receptors (EGF Receptor)IBA 01/2011
1	Oncogene Proteins (Oncogene Protein)IBA 11/2010
1	Anti-Idiotypic AntibodiesIBA 08/2008
1	Genetic Markers (Genetic Marker)IBA 08/2008
1	oleylamide (oleamide)IBA 07/2007
1	Connexin 26IBA 07/2007
1	NocodazoleIBA 10/2006
1	Chemokine ReceptorsIBA 08/2006
1	NF-kappa B (NF-kB)IBA 08/2006
1	Tacrolimus Binding Proteins (FKBP)IBA 08/2006
1	C-Type Lectins (C-Type Lectin)IBA 08/2006
1	protein-tyrosine sulfotransferase (tyrosylprotein sulfotransferase)IBA 08/2006
1	Lysosomal Membrane ProteinsIBA 02/2006

Therapy/Procedure

3	Therapeutics 02/2019 - 11/2015
1	Subcutaneous Injections 01/2013
1	Intraperitoneal Injections 07/2007